Pharmafile Logo
Pharmafocus logo
Advanced Search

Diurnal

Showing 2 posts of 2 posts found.

Diurnal and Citrine sign licensing agreement for Alkindi

January 27, 2021
Research and Development Citrine, Diurnal

Diurnal Group has entered into an exclusive licence agreement for its product Alkindi (hydrocortisone granules in capsules for opening) with …

News
turkey_flag

Diurnal joins Er-Kim to distribute cortisol deficiency treatments in Turkey

January 13, 2021
Research and Development Diurnal, Diurnal Group, Er-Kim, Turkey

Diurnal Group, a specialty pharmaceutical company targeting patient needs in chronic endocrine diseases, has announced a distribution agreement with Er-Kim, …

News
The Gateway to Local Adoption Series

Latest content

NICE recommends daratumumab quadruplet for newly diagnosed multiple myeloma

October 8, 2026

AstraZeneca’s Trixeo approved in EU for asthma

October 8, 2026

Amplio reports early human data for novel methotrexate approach in rheumatoid arthritis

October 7, 2026

Survodutide delivers up to 13.1% weight loss in phase 3 obesity and diabetes trial

October 6, 2026

ESTEVE CDMO adds $17.5m to Illinois expansion

October 6, 2026